Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...

In single-center study, GLP-1 use in people with type 1 diabetes was associated with lower hospitalization rates.

Recent research and clinical updates highlight how GLP-1 receptor agonists are transforming diabetes and obesity care, with expanding uses from adolescents with type 2 diabetes to off-label ...

Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart disease, or lose weight.  “At this time, there is no other medication like ...

Obesity therapeutics now represent ~$98B and 4.6% share, climbing to the fourth-largest category, with ~190 pipeline assets ...

Weight loss medications known as GLP-1s are gaining attention not only for helping people shed pounds, but also for potential ...

New research explains the role of genes and other health factors.

Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...

An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid ...

Q: A few years ago, you mentioned a study on the idea that GLP-1 drugs might have a protective effect for people with ...